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Bile acids may be involved in the regulation of food intake and energy metabolism. The
aim of the study was to investigate the association of plasma bile acids with body mass
index (BMI) and the possible involvement of circulating bile acids in the modulation of
physical activity and eating behavior. Blood was obtained in a group of hospitalized
patients with normal weight (BMI 18.5–25 kg/m2), underweight (anorexia nervosa,
BMI < 17.5 kg/m2) and overweight (obesity with BMI 30–40, 40–50 and >50 kg/m2,
n = 14–15/group) and plasma bile acid concentrations assessed. Physical activity and
plasma bile acids were measured in a group of patients with anorexia nervosa (BMI
14.6 ± 0.3 kg/m2, n = 43). Lastly, in a population of obese patients (BMI 48.5 ±
0.9 kg/m2, n = 85), psychometric parameters related to disordered eating and plasma
bile acids were assessed. Plasma bile acids showed a positive correlation with BMI
(r = 0.26, p = 0.03) in the population of patients with broad range of BMI (9–85 kg/m2,
n = 74). No associations were observed between plasma bile acids and different
parameters of physical activity in anorexic patients (p > 0.05). Plasma bile acids were
negatively correlated with cognitive restraint of eating (r = −0.30, p = 0.008), while no
associations were observed with other psychometric eating behavior-related parameters
(p > 0.05) in obese patients. In conclusion, these data may point toward a role of bile
acids in the regulation of body weight. Since plasma bile acids are negatively correlated
with the cognitive restraint of eating in obese patients, this may represent a compensatory
adaptation to prevent further overeating.
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Introduction
Obesity is a growing health problem and predominantly responsible for morbidity and
mortality (Ogden et al., 2006; James, 2008) due to its associated diseases such as
type 2 diabetes mellitus, dyslipidemia and arteriosclerosis (Hevener and Febbraio, 2010)
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but also gastrointestinal diseases including certain forms of
cancer, namely hepatocellular, colorectal, and pancreatic cancer
(Calle et al., 2003). The prevalence continues to rise (Finucane
et al., 2011) and is expected to reach 700 million obese people
worldwide in 2015 (James, 2008). Therefore, the term “globesity”
was introduced by the world health organization.
While treatment options—especially drug treatment—are
limited so far (Bray, 2014), a better understanding of the
regulation of hunger and satiety, energy expenditure and body
weight is necessary. Hunger and satiety are predominantly
regulated by peptidergic hormones (Hussain and Bloom, 2013),
most of which are derived from the gastrointestinal tract
(Suzuki et al., 2012). These encompass—among others—ghrelin,
NUCB2/nesfatin-1 (Stengel and Taché, 2012), cholecystokinin,
oxyntomodulin, pancreatic polypeptide, glucagon-like peptide 1
(GLP-1), and peptide YY (PYY) (Suzuki et al., 2012).
However, also other factors, particularly bile acids, have been
hypothesized to be involved in the regulation of food intake.
Since 95% of bile acids undergo enterohepatic circulation and
are reabsorbed in the terminal ileum reaching the liver via
the systemic circulation, bile acid levels can be assessed in
stool as well as in blood (plasma, serum). Early on, an effect
of bile acids on appetite has been described with a decrease
following oral application of bile acids in obese patients (Bray and
Gallagher, 1968), although the mechanisms involved remained
unclear. More recently, an interaction of bile acids and food
regulatory hormones has been identified. Rectal administration
of taurocholic acid was reported to increase circulating levels of
GLP-1 and PYY in healthy volunteers which may lead to the
observed increase of fullness (Wu et al., 2013). This is likely to be
a physiological effect as endogenous taurochenodeoxycholic acid
showed positive correlations with the anorexigenic hormones
GLP-1 and PYY, while a negative association with the orexigenic
ghrelin was observed in healthy human subjects (Roberts
et al., 2011). However, the possible role of bile acids in
the modulation of eating behavior is yet to be further
investigated.
The regulation of bile acids has been first studied under
conditions of obesity indicating a blunted postprandial response
of bile acids which could lead to a reduced anorexigenic signaling
under these conditions (Glicksman et al., 2010). However, it
is unclear whether bile acid levels are per se altered under
conditions of chronically altered body weight.
Since physical activity—besides food intake—is a major
determinant of body weight, a possible association of bile acids
with physical activity has been investigated in few studies. One
group reported reduced fecal bile acid levels in subjects with
higher recreational physical activity compared to subjects of
the lowest quartile of recreational physical activity (Wertheim
Abbreviations: BCM, body cell mass; BIA, bioelectrical impedance analysis; BMI,
body mass index; EAT, exercise-related activity thermogenesis; ECM, extracellular
mass; EDI, Eating disorder inventory; FFM, fat free mass; FM, fat mass; GAD-7,
Generalized Anxiety Disorder 7-item scale; MET, metabolic equivalent of a task;
NEAT, non-exercise activity thermogenesis; PHQ-9, Patient Health Questionnaire;
PSQ-20, Perceived Stress Questionnaire 20-item scale; REE, resting energy
expenditure; TBW, total body water; TEE, total energy expenditure; TEF, thermic
effect of food; TFEQ, Three-Factor Eating Questionnaire.
et al., 2009). However, an animal study showed increased fecal
bile acid levels in voluntarily wheel running mice compared to
sedentary controls (Meissner et al., 2011). Whether this merely
reflects species differences or whether other factors are important
remains to be established.
The aim of the present study was to investigate a possible
association of circulating bile acids with body mass index
(BMI) over a broad range (BMI 9–85 kg/m2) in order to
describe a modulation/adaptation under these conditions.
Possible confounding factors such as cholesterol levels, statin
use, and parameters of glucose control were assessed as well.
Moreover, we studied a possible association of plasma bile acids
and physical activity in a population of patients with anorexia
nervosa, a disease that is often associated with significantly
increased physical activity (Davis et al., 1997). Lastly, we also
investigated a possible association of total plasma bile acids and
eating behavior in obese patients with a broad range of disordered
eating using well established questionnaires, namely the Eating
Disorder Inventory (Garner et al., 1983; Paul and Thiel, 2004) and
the Three-Factor Eating Questionnaire (Stunkard and Messick,
1985; Pudel and Westerhofer, 1989). Since obesity is often
accompanied by other psychological disturbances (Gariepy et al.,
2010; Luppino et al., 2010), we also assessed perceived stress,
depressiveness, and anxiety.
Materials and Methods
Subjects
All patients were hospitalized in the Division of Psychosomatic
Medicine at Charité-Universitätsmedizin Berlin and gave written
informed consent. Blood collection was performed on day 1, 2,
or 3 after hospital admission before the onset of changes due to
dietary treatment to increase or reduce body weight, respectively.
All parameters were assessed on the same morning. The protocol
was approved by the local ethics committee for human research
(ethics committee Charité—Universitätsmedizin Berlin, Campus
Charité Mitte, protocol number EA1/114/10).
For the investigation of a possible association of circulating
bile acids with body weight, a total of 75 subjects (a) participated
in this study and were divided into five groups: normal weight
(BMI 18.5–25 kg/m2, 8 female, 7 male, age 21–61), underweight
(anorexia nervosa, BMI < 17.5 kg/m2, 15 female, age 18–44)
and overweight (different stages of obesity: BMI 30–40 kg/m2,
age 21–61; BMI 40–50 kg/m2, age 20–68; and BMI > 50 kg/m2,
age 28–73; n = 15/group with 8 female, 7 male/group). One
patient took ursodesoxycholic acid and was therefore excluded
from the analysis resulting in a final n = 74. The anthropometric
characteristics are indicated in Table 1.
In another cohort (b) of 43 female anorexic patients (age 18–
52) the possible association of circulating bile acids with physical
activity was investigated. The anthropometric characteristics are
indicated in Table 3.
Lastly, a population of 85 female obese patients (c, age 19–
73) was investigated to study the association of plasma bile acids
with psychometric parameters involved in eating behavior. The
anthropometric characteristics are indicated in Table 5.
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TABLE 1 | Anthropometric characteristics of patient population with broad
range of body mass index.
Group Body weight (kg) BMI (kg/m2)
Mean ± SEM Range Mean ± SEM Range
Anorexia nervosa (15f) 35.9± 1.2 29.3–42.2† 13.1±0.5 8.9–15.6
Normal weight (8f, 7m) 66.5± 2.7 53.3–79.9† 22.1±0.3 20.3–25.0
Obesity BMI 30–40 (8f, 7m) 113.7± 3.2 91.4–140.6† 37.6±0.7 30.1–39.8
Obesity BMI 40–50 (8f, 6m) 135.5± 3.8 113.5–161.0† 45.6±0.8 41.1–49.7
Obesity BMI > 50 (8f, 7m) 194.4± 7.9 151.8–261.9† 67.1±1.8 59.0–84.6
N = 14–15/group. Distribution of the data was determined by using the Kolmogorov-
Smirnov test.
†
Indicates normal distribution. BMI, body mass index; f, female; m,
male.
All subjects were devoid of a history for gastrointestinal
surgery. Exclusion criteria also encompassed an age < 18
years, current pregnancy and non-treated psychotic diseases.
All normal weight patients were hospitalized exclusively due
to psychosomatic disorders with functional bodily symptoms
(functional gastrointestinal symptoms excluded) without
relevant somatic disorders. Anorexic and obese patients were
diagnosed according to the International Classification of
Diseases-10 (ICD-10) and hospitalized for weight gain or weight
loss therapy, respectively. In obese patients hypercortisolism was
excluded by assessment of urinary free cortisol excretion in a
24 h sample or—in case of clinical suspicion—with an overnight
low-dose dexamethasone suppression test.
Blood Collection
After an overnight fast, venous blood was withdrawn between
07:00 and 08:00 a.m. in cooled EDTA tubes containing aprotinin
(0.6 trypsin inhibitor/0.5ml blood; ICN Pharmaceuticals, Costa
Mesa, CA, USA) and immediately centrifuged at 3000 rpm
for 10min at 4◦C. Plasma was separated and aliquots stored
at −80◦C until further processing. Patients were advised not to
smoke or exercise that morning.
Measurements
Bile Acid Concentration
Plasma levels of total bile acids were determined using a
commercial total bile acid assay kit (# BQ 042A-EALD, BQ
Kits Inc., San Diego, CA, USA). The enzyme 3-α-hydroxysteroid
dehydrogenase oxidates bile acids to 3-keto steroids in the
presence of Thio-NAD which is reduced to Thio-NADH. The
absorbance of Thio-NADH can be quantitatively measured
and is used to indirectly determine the levels of total bile
acids. Samples were prepared according to the manufacturer’s
protocol, incubated for 3min at 37◦C and the absorbance
was measured at 405 nm 1 and 2min after incubation. All
samples were processed in one batch. The intra-assay variability
was 9.3%.
Blood Glucose, Serum Insulin, Triglycerides, and
Cholesterol
Parameters such as blood glucose and serum insulin,
triglycerides, and cholesterol were analyzed using the routine
laboratory analyses (Charité-Universitätsmedizin Berlin).
Oral Glucose Tolerance Test
Overnight fasted patients received a standardized oral glucose
solution (75 g) and blood was withdrawn before and at 1–2 h post
ingestion to analyze blood glucose and serum insulin levels.
Body Weight and Body Mass Index
Body weight and height were assessed in overnight fasted subjects
wearing underwear only. BMI was calculated as kg/m2.
Abdominal Ultrasound
Patients underwent routine abdominal ultrasound examination
to exclude or diagnose fatty liver disease.
Body Composition
Body composition was estimated using bioelectrical impedance
analysis (BIA) which was performed on the day of the
blood withdrawal between 10:30 a.m. and 01:00 p.m. after
a fasting period of at least 2 h as described before (Stengel
et al., 2013). Briefly, BIA was performed under standardized
conditions (patient in supine position, arms relaxed at the
sides without touching the body, and thighs separated) using
a bioelectrical impedance analyzer (Nutrigard-M, Data Input,
Darmstadt, Germany) and corresponding electrodes (Bianostic-
AT, Data Input, Germany). Before bioimpedance testing, fasted
patients voided, and had an equilibration period of 30min in
the supine position. Total body water (TBW), fat free mass
(FFM), extracellular mass (ECM), body cell mass (BCM, best
reflecting muscle mass and muscle containing compartments of
the body) and fat mass (FM) were obtained using the equations
provided by the manufacturer’s software (NutriPlus, Data Input,
Germany).
Physical Activity
Physical activity was continuously measured for 3 days
during inpatient treatment around the time of the blood
withdrawal using a portable armband device (SenseWear™
PRO3 armband; BodyMedia Inc., Pittsburgh, PA, USA) as
recently described (Hofmann et al., 2014). Briefly, 1 day
was included in the data analysis if the minimum duration
of data acquisition was 20 h and 30min per day. Patients
were not activity restricted during the measurement. Although
activity patterns under conditions of hospitalization may differ
from those in daily life, activity habits are likely to persist
during inpatient treatment if activity is not restricted due
to a genetic influence on physical activity (Joosen et al.,
2005). The SenseWear™ armband device uses a multisensory
array including sensors measuring heat flux, galvanic skin
response, skin temperature, near-body ambient temperature
and a 2-axis accelerometer. Step counts were measured by the
accelerometer and directly taken for analyses. Obtained data were
analyzed using a generalized proprietary algorithm developed
by the manufacturer (SenseWear™ Software, Version 6.1,
BodyMedia Inc.).
Total energy expenditure (TEE) consists of resting energy
expenditure (REE), thermic effect of food (TEF) and activity
thermogenesis. Activity thermogenesis can be further separated
into two components: exercise-related activity thermogenesis
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(EAT, deliberate physical exercise, sports) and non-exercise
activity thermogenesis (NEAT, spontaneous daily physical
activity) (Levine et al., 1999). Energy expenditure of more than
five metabolic equivalents of a task (METs, a physiological
measure expressing the energy cost of physical activities) was
classified as EAT, whereas energy expenditure of up to five
METs was classified as NEAT as described before (Ainsworth
et al., 2000; Elbelt et al., 2010). While TEE, exercise activity
thermogenesis (EAT) and duration of exercise were directly
received from the proprietary algorithms of the SenseWear™
armband device, NEAT was calculated according to the equation:
NEAT = TEE–thermic effect of food (TEF)–REE–EAT. TEF
was estimated as 10% of TEE and calculated as TEE ×
0.1 (Levine, 2002). REE, required for calculation of NEAT,
was calculated using weight-specific REE prediction equations
(Muller et al., 2004) since REE cannot be directly determined by
the SenseWear™ armband device.
Psychometric Parameters
Psychometric parameters were assessed on the day of the blood
withdrawal using an electronic handheld device.
The Three-Factor Eating Questionnaire (TFEQ) (Stunkard
and Messick, 1985) employs 66 items to assess eating behavior
on 3 scales: “cognitive restraint of eating,” “disinhibition,” and
“hunger.” We used the German version (Pudel and Westerhofer,
1989).
The Eating Disorder Inventory (EDI) (Garner et al., 1983)
was developed to assess symptoms of disordered eating in
anorexic and bulimic patients encompassing 64 items on
8 subscales, namely “drive for thinness,” “bulimia,” “body
dissatisfaction,” “ineffectiveness,” “perfectionism,” “interpersonal
distrust,” “interoceptive awareness,” and “maturity fears.” We
used the German version (Thiel et al., 1997) of the 2nd version
(Garner, 1991) which added three subscales to the original one,
but only used the first eight subscales of the EDI-2 mentioned
above. Sum scores of all scales were converted into percentage
values ranging from 0 to 100.
Two scales of the patient health questionnaire (PHQ) (Spitzer
et al., 1999) were carried out to assess general anxiety (GAD-7)
and depression (PHQ-9). The German version of the GAD-7
(Lowe et al., 2008), a 7-item scale was primarily designed to
diagnose general anxiety disorder (Spitzer et al., 2006) but
is also sensitive as a screening tool for panic, social anxiety
and posttraumatic stress disorders. The widely used PHQ-9
depression scale (Spitzer et al., 1999) is a 9-item screening
instrument for the diagnosis of major depression and the
evaluation of severity of depressive symptoms which was used in
the German version (Löwe et al., 2002).
The perceived stress questionnaire (PSQ) (Levenstein et al.,
1993) used in its revised German 20-item version (PSQ-
20) (Fliege et al., 2005) is an instrument based on a stress
concept that emphasizes the subjective experience and—
besides an overall score—allows to evaluate the four subscales
“worries,” “tension,” “joy” as stress responses and “demands”
as the perception of external stressors. Sum scores of all
scales were converted into percentage values ranging from
0 to 100.
FIGURE 1 | Plasma bile acids show a positive association with body
weight. The study population was divided into five groups: underweight
(anorexia nervosa), normal weight, and overweight (obese subjects with BMI
between 30–40, 40–50, and > 50 kg/m2). The plasma concentration of bile
acids shows an increase with BMI reaching significance in the obese group
with BMI > 50 kg/m2 compared to the anorexic and normal weight group (A).
A positive correlation is observed between plasma bile acids and body weight
(B) as well as BMI (C). Values for r and p are indicated in the correlation
graphs. Data in (A) are expressed as mean ± sem of n = 14–15
subjects/group. *p < 0.05 vs. normal weight and #p < 0.05 vs. anorexia
nervosa.
Statistical Analysis
Distribution of the data was determined by using the
Kolmogorov-Smirnov test. Data are expressed as mean ±
standard error of the mean (SEM). Differences between two
groups were assessed using the t-test, differences between more
groups were calculated using One-Way analysis of variance
(ANOVA) followed by Tukey post-hoc test (study population a).
Correlations were determined by Pearson’s or Spearman’s
analysis depending on the distribution of the data (study
populations a, b, and c). Differences between groups were
considered significant when p < 0.05. All statistical analyses
were conducted using SigmaStat 3.1 (Systat Software, San Jose,
CA, USA).
Results
Plasma Bile Acids Show a Positive Correlation
with Body Mass Index
A population of 74 subjects with a broad range of BMI (8.9–
84.6 kg/m2, cohort a) was divided into five groups depending
on their BMI (Table 1). Total plasma bile acids were similar
in patients with normal weight and anorexia nervosa (p =
0.66) but showed a gradual increase with increasing BMI with
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TABLE 2 | Comorbidities and medication of the three study populations (a, b, and c).
Parameter Broad range of body mass index (n = 74) Broad activity
pattern (n = 43)
Broad range of
disordered
eating (n = 85)Anorexia
nervosa
(n = 15)
Normal
weight
(n = 15)
Obesity BMI
30–40kg/m2
(n = 15)
Obesity BMI
40–50kg/m2
(n = 14)
Obesity BMI
> 50kg/m2
(n = 15)
COMORBIDITIES
Type 2 diabetes
mellitus
0 (0.0%) 0 (0.0%) 4 (26.7%) 3 (21.4%) 6 (40.0%) 0 (0.0%) 19 (22.4%)
Impaired fasting
glucose
n.t. n.t. 0 (0.0%) 1 (7.1%) 0 (0.0%) n.t. 4 (4.7%)
Insulin resistance with
normal glucose control
n.t. n.t. 0 (0.0%) 3 (21.4%) 3 (20.0%) n.t. 22 (25.9%)
Arterial hypertension 0 (0.0%) 2 (13.3%) 7 (46.7%) 9 (64.3%) 10 (66.7%) 0 (0.0%) 40 (47.1%)
Hypercholesterinemia 1 (6.7%) 1 (6.7%) 5 (33.3%) 5 (35.7%) 9 (60.0%) 8 (18.6%) 39 (45.9%)
Hypertriglyceridemia 0 (0.0%) 0 (0.0%) 2 (13.3%) 3 (21.4%) 4 (26.7%) 0 (0.0%) 16 (18.8%)
Hyperuricemia 0 (0.0%) 0 (0.0%) 2 (13.3%) 4 (28.6%) 9 (60.0%) 1 (2.3%) 32 (37.6%)
Fatty liver disease 0 (0.0%) 0 (0.0%) 9 (60.0%) 9 (64.3%) 3 (20.0%) 0 (0.0%) 48 (56.5%)
MEDICATION
Oral antidiabetics 0 (0.0%) 0 (0.0%) 1 (6.7%) 1 (7.1%) 2 (13.3%) 0 (0.0%) 10 (11.8%)
Insulin 0 (0.0%) 0 (0.0%) 1 (6.7%) 1 (7.1%) 0 (0.0%) 0 (0.0%) 3 (3.5%)
Statins 0 (0.0%) 0 (0.0%) 1 (6.7%) 0 (0.0%) 4 (26.7%) 0 (0.0%) 11 (12.9%)
Psychopharmacologicals 3 (20.0%) 2 (13.3%) 4 (26.7%) 1 (7.1%) 3 (20.0%) 7 (16.3%) 27 (31.8%)
Values are given in total numbers (% in parentheses). AN, anorexia nervosa; BMI, body mass index; n.t., not tested.
highest levels in the obese group with BMI 40–50 kg/m2 (+121%
compared to normal weight group, Figure 1A). However, due to
the high variation in the BMI group 40–50 kg/m2 significance
for plasma bile acids was reached in the BMI > 50 kg/m2 group
only compared to normal weight (+51%, p = 0.04) and anorexia
nervosa (+66%, p = 0.02; Figure 1A). Analysis of all five BMI
groups showed a positive correlation of total plasma bile acid
levels and body weight (r = 0.28, p = 0.02; Figure 1B) as well as
BMI (r = 0.26, p = 0.03; Figure 1C).
While in the group of anorexia nervosa only female subjects
were included, all other groups contained female as well as
male subjects (Table 1). No sex differences were observed for
total plasma bile acid levels in female vs. male subjects (p =
0.17; data not shown). Lastly, no correlation of bile acids
and age was observed (r = −0.12, p = 0.32; data not
shown).
Plasma Bile Acids are Not Associated with
Circulating Glucose or Cholesterol Levels
To exclude possible confounding factors we analyzed the
population of 74 subjects with broad range of BMI also with
regards to comorbidities (Table 2). No correlation was observed
between fasting circulating glucose and bile acid levels (r = 0.09,
p = 0.47; data not shown). In addition, no differences in fasting
total plasma bile acid levels in obese patients with or without type
2 diabetes were detected (population of patients with broad range
of BMI: n = 44 obese, n = 13 with type 2 diabetes mellitus, n =
31 without, p = 0.18 for comparison of plasma bile acids between
both groups; for BMI p = 0.65; data not shown). Moreover,
no correlation was observed between circulating cholesterol and
plasma bile acid levels (r = 0.13, p = 0.27; data not shown).
Lastly, after exclusion of patients with arterial hypertension (r =
0.32, p = 0.03), fatty liver disease (r = 0.28, p = 0.04) or
psychopharmacological treatment (r = 0.28, p = 0.03), the
positive association of bile acids and BMI remained visible (data
not shown).
Plasma Bile Acids are Not Associated with
Parameters of Physical Activity and Body
Composition in Patients with Anorexia Nervosa
To investigate a possible association of circulating bile acids with
physical activity a population of patients with anorexia nervosa
with broad activity pattern (cohort b) was included (n = 43,
steps/day: 2479–26047, Table 3). Total plasma bile acids did not
show any correlation with parameters of body composition or
physical activity (Figure 2, Table 4).
Plasma Bile Acids Show a Negative Association
with Cognitive Restraint of Eating
Next, we investigated a possible association of plasma bile acids
with psychometric parameters in a population of obese patients
with broad spectrum of disordered eating (cohort c, n = 85,
EDI-2 total score: 20.4–79.4, Table 5). Total plasma bile acids
showed a negative correlation with cognitive restraint of eating
(r = −0.30, p = 0.01), while no correlation was observed
with disinhibition (r = −0.12, p = 0.29) and hunger
(TFEQ; r = 0.04, p = 0.74; Figure 3; Table 6). Similarly, no
correlation of plasma bile acids was detected with the total score
(Figure 3) or subscales (“drive for thinness,” “bulimia,” “body
dissatisfaction,” “ineffectiveness,” “perfectionism,” “interpersonal
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TABLE 3 | Anthropometric characteristics, body composition, and
physical activity parameters in a population of anorexic patients with
broad activity pattern.
Parameter Mean ± SEM Range
ANTHROPOMETRIC CHARACTERISTICS
Body weight (kg) 40.3± 1.0 28.1–52.0†
Body mass index (kg/m2) 14.6± 0.3 10.8–17.7†
BODY COMPOSITION
Fat mass (kg) 2.8± 0.8 0.0–14.8‡
Body cell mass (kg) 15.9± 0.4 8.4–21.4†
Fat free mass (kg) 37.2± 0.6 28.6–45.1†
Extracellular mass (kg) 21.3± 0.6 15.4–33.9‡
Total body water (l) 27.2± 0.4 20.9–33.0†
PHYSICAL ACTIVITY
Steps/d 10112± 728 2479–26047‡
Metabolic equivalents/d 1.8± 0.0 1.4–2.5‡
Total energy expenditure (kcal/kg/d) 43.5± 0.8 33.5–59.3‡
Resting energy expenditure (kcal/kg/d) 17.9± 0.2 14.8–19.5‡
Duration of exercise (min/d) 21.8± 11.0 0.0–471.0‡
Exercise activity thermogenesis (kcal/kg/d) 1.8± 0.8 0.0–31.7‡
Non exercise activity thermogenesis (kcal/kg/d) 19.5± 0.7 1.8–29.1‡
N = 43, all female. Distribution of the data was determined by using the
Kolmogorov-Smirnov test.
†
indicates normal distribution, non-normal distribution.
distrust,” “interoceptive awareness,” and “maturity fears”) of the
EDI-2 questionnaire (Table 6).
Since other psychological conditions may also affect eating
behavior, we additionally investigated depressiveness, anxiety,
and stress in the present population. However, no association was
observed between total plasma bile acid levels and depressiveness
(PHQ-9), anxiety (GAD-7) and stress (PSQ-20; Table 6).
Discussion
In the present study we show that total plasma bile acids are
higher in obese compared to normal weight and anorexic subjects
which is reflected in a positive correlation with body mass index.
These data are in line with an early study showing higher serum
bile acid levels in overweight compared to ideal weight subjects
(Halmy et al., 1986). The present study extends these findings
by investigating the circulating bile acid levels over a very broad
BMI spectrum (9–85 kg/m2). This increase is unlikely to depend
on an increase in cholesterol levels as there was no association
of circulating cholesterol and bile acid levels. It is to note that
bile acids are not only produced by the liver but also by bacteria
of the intestinal microbiota (Yoshimoto et al., 2013; Joyce et al.,
2014). Since emerging evidence points toward greatly altered
gut microbiota under conditions of obesity (Tilg et al., 2009;
Deweerdt, 2014), this is likely to contribute to the altered plasma
bile acid concentrations observed here.
Interestingly, besides this positive association, also the bile
acid receptor, G protein-coupled bile acid receptor 1 (TGR5),
expressed in white adipose tissue showed a positive correlation
with body mass index (Svensson et al., 2013). Since this receptor
is involved in the mediation of bile acid-induced release of
FIGURE 2 | Plasma bile acids do not show a correlation with body
composition or energy expenditure in patients with anorexia nervosa.
The study population consisted of 43 anorexic subjects with broad activity
pattern. Body composition was assessed using bioelectrical impedance
analysis; physical activity was monitored with a portable armband device. No
correlation was observed between plasma bile acids and fat mass (A), fat free
mass (B), physical activity expressed as steps/d (C) and total energy
expenditure (D). Values for r and p are indicated in the correlation graphs.
TABLE 4 | Correlation of plasma bile acids with physical activity in a
population of anorexic patients with broad activity pattern.
Parameter r p
BODY COMPOSITION
Fat mass (kg) −0.099 0.532
Body cell mass (kg) −0.188 0.233
Fat free mass (kg) 0.062 0.696
Extracellular mass (kg) 0.193 0.220
Total body water (l) 0.058 0.715
PHYSICAL ACTIVITY
Steps/d 0.137 0.388
Metabolic equivalents/d 0.162 0.304
Total energy expenditure (kcal/kg/d) 0.147 0.352
Resting energy expenditure (kcal/kg/d) 0.043 0.788
Duration of exercise (min/d) 0.090 0.570
Exercise activity thermogenesis (kcal/kg/d) 0.104 0.512
Non exercise activity thermogenesis (kcal/kg/d) 0.035 0.825
N = 43, all female.
GLP-1 (Thomas et al., 2009), enhanced signaling of this pathway
on the level of the receptor and the ligand may result in
increased anorexigenic signaling to prevent further overeating
under conditions of obesity. On the other hand, higher levels
of bile acids may also increase the risk for malignomas such as
hepatocellular carcinoma (Yoshimoto et al., 2013), an effect that
is likely related to the potential of deoxycholic acid to cause DNA
damage (Kitazawa et al., 1990). This property has to be kept in
mind when considering potential therapeutic implications of bile
acids.
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TABLE 5 | Anthropometric and psychometric characteristics in a
population of obese patients with broad spectrum of disordered eating
and depressiveness.
Parameter Mean ± SEM Range
ANTHROPOMETRIC CHARACTERISTICS
Body mass index (kg/m2) 48.5±0.9 31.8–68.7†
EATING HABITS
TFEQ
- Cognitive restraint 8.5±0.5 0–21‡
- Disinhibition 9.6±0.4 1–15‡
- Hunger 7.7±0.5 0–14‡
EDI total 46.2±1.4 20–79†
- Drive for thinness 27.9±0.8 11–41†
- Bulimia 17.5±0.8 7–37‡
- Body dissatisfaction 49.5±0.7 24–54‡
- Ineffectiveness 31.0±1.1 15–54†
- Perfectionism 18.5±0.7 7–34†
- Interpersonal distrust 23.7±0.7 10–38†
- Interoceptive awareness 28.4±0.9 10–55†
- Maturity fears 24.8±0.8 11–44†
DEPRESSIVENESS
PHQ-9 10.0±0.7 0–25†
ANXIETY
GAD-7 9.3±0.6 0–21‡
STRESS
PSQ total 54.9±2.4 5–98†
- Worries 53.3±3.0 0–100‡
- Tension 58.4±2.9 0–100†
- Joy 40.6±2.5 0–100‡
- Demands 48.7±2.8 0–100†
N = 85, all female. Distribution of the data was determined by using the Kolmogorov-
Smirnov test.
†
indicates normal distribution,
‡
non-normal distribution. EDI, eating disorder
inventory; GAD-7, Generalized Anxiety Disorder questionnaire; PHQ-9, patient health
questionnaire; PSQ-20, perceived stress questionnaire 20-item scale; TFEQ, Three-
Factor Eating Questionnaire.
Bile acids have been investigated in the context of obesity-
associated diseases, especially type 2 diabetes mellitus. Patients
with type 2 diabetes mellitus displayed higher levels of circulating
bile acids compared to healthy non-diabetic controls (Haeusler
et al., 2013; Wewalka et al., 2014). This was also reflected
in a positive correlation of circulating bile acids with insulin
resistance in patients with and without type 2 diabetes (Cariou
et al., 2011). However, another study described similar levels of
baseline circulating bile acids in patients with type 2 diabetes
and normoglycaemic controls (Vincent et al., 2013). Similarly,
in the present study we did not detect any differences in fasting
total plasma bile acid levels in obese patients with or without
type 2 diabetes. However, these data have to be interpreted
with caution as the group size of diabetic patients is small and
only basal plasma levels of bile acids have been investigated,
while differences may emerge under stimulated postprandial
conditions as reported before (Vincent et al., 2013).
After describing the dependency of plasma bile acids with
body mass index, we studied the possible association of
circulating bile acids with body composition and physical activity
in a population of anorexic subjects with widely differing levels
FIGURE 3 | Plasma bile acids show a negative association with
cognitive restraint of eating in obese patients. A population of obese
patients (n = 85) with broad spectrum of disordered eating was investigated.
Eating behavior was assessed using the Three-Factor Eating Questionnaire
and the Eating Disorder Inventory. Plasma bile acids were negatively correlated
with cognitive restraint of eating (A), while no association was observed with
disinhibition (B), hunger (C) and the EDI-2 total score (D). Values for r and p
are indicated in the correlation graphs. Abbreviations: EDI-2, eating disorder
inventory; TFEQ, Three-Factor Eating Questionnaire.
of physical exercise. In this population no associations between
plasma bile acids and different parameters of body composition,
as assessed non-invasively by bioelectrical impedance analysis,
were observed. In light of the positive association of bile
acids with BMI observed in the present study, a recent study
surprisingly described a negative association of body fat mass and
bile acids in healthy normal weight subjects (Suzuki et al., 2014).
These differences may be due to the investigation of fasting bile
acid levels in the present vs. postprandial concentrations in the
study of Suzuki and colleagues (Suzuki et al., 2014). Moreover,
one has to keep in mind that the population of anorexic subjects
might have too low amounts of body fat to study possible
associations.
Anorexic patients showed a wide range of physical exercise
behavior which was monitored using the SenseWear™ armband
device used before in obese (Elbelt et al., 2010) and anorexic
(Hofmann et al., 2014) patients. No associations were observed
between levels of circulating bile acids and various markers
of physical activity and energy expenditure. These data may
indicate that plasma bile acids are not affected by physical
activity, at least not under conditions of greatly reduced body
weight. However, one previous study showed a reduction of
fecal bile acid levels in subjects with higher recreational physical
activity compared to lower recreational activity (Wertheim et al.,
2009). These differences may be explained by the differences
in the study sample (anorexic vs. overweight subjects), type
of assessment (Sensewear™ vs. self-administered questionnaire)
and most importantly the location of bile acid measurement
(plasma vs. stool).
Nonetheless, bile acids are discussed to play a role in the
mediation of energy expenditure. The TGR5 is not only expressed
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TABLE 6 | Correlation of plasma bile acids with psychometric parameters
in a population of obese patients with broad spectrum of disordered
eating, depressiveness, anxiety, and stress.
Parameter r p
EATING HABITS
TFEQ
- Cognitive restraint of eating −0.300 0.008
- Disinhibition −0.121 0.290
- Hunger 0.038 0.744
EDI total −0.106 0.354
- Drive for thinness −0.103 0.368
- Bulimia −0.058 0.617
- Body dissatisfaction −0.076 0.507
- Ineffectiveness −0.122 0.289
- Perfectionism −0.116 0.312
- Interpersonal distrust −0.011 0.922
- Interoceptive awareness 0.024 0.835
- Maturity fears −0.041 0.720
DEPRESSIVENESS
PHQ-9 −0.128 0.256
ANXIETY
GAD-7 −0.114 0.309
STRESS
PSQ-20 total −0.171 0.127
- Worries −0.196 0.080
- Tension −0.095 0.399
- Joy 0.152 0.175
- Demands −0.131 0.244
N = 85, all female. Significant correlations are displayed in bold. EDI, eating disorder
inventory; GAD-7, Generalized Anxiety Disorder questionnaire; PHQ-9, patient health
questionnaire; PSQ-20, perceived stress questionnaire 20-item scale; TFEQ, Three-
Factor Eating Questionnaire.
in white but also human brown adipose tissue (Svensson et al.,
2013), a tissue crucially involved in non-shivering thermogenesis
and energy expenditure (Cannon and Nedergaard, 2004; Cypess
et al., 2009). Supporting the functional relevance of the receptor
in this tissue, exogenous administration of bile acids increased
energy expenditure in mice (Watanabe et al., 2006). This led
to the hypothesis of using natural or semisynthetic ligands of
the TGR5 in the drug treatment of obesity (Chen et al., 2011).
In humans, expression of TGR5 showed a positive correlation
with body weight as well as resting energy expenditure (Svensson
et al., 2013), which might represent a physiological adaptation
of the body to combat further body weight increase. Since
regulation on the receptor level alone may not be sufficient,
one would expect adaptation of the ligand as well. However, in
line with the current study another group did not detect any
correlation between circulating bile acids and energy expenditure
in healthy or type 2 diabetic patients (Brufau et al., 2010).
Further studies are warranted to investigate whether an increase
(either endogenous or pharmacological) of circulating bile acids
will stimulate energy expenditure and subsequently reduce body
weight under conditions of obesity in humans.
Since—besides energy expenditure—food intake and related
eating behavior is of utmost importance for body weight
regulation especially under conditions of obesity, we next
investigated a possible association of plasma bile acids with
parameters of eating behavior in a population of obese subjects
with a broad range of disordered eating. To exclude any possible
sex differences only female subjects were investigated. Total
plasma bile acids were negatively associated with the cognitive
restraint of eating, while other parameters directly or secondarily
related to eating behavior were not. One might speculate that in
patients with lower cognitive restraint (patients were hospitalized
for body weight reduction) the increase of plasma bile acids
represents a mechanism to reduce food intake and body weight.
Alternatively, since obese patients display higher bile acid levels,
these individuals could also present with less cognitive restraint
of eating without direct link to bile acids. Therefore, the possible
connection has to be further investigated.
Despite the strength of the study of investigating study
populations with broad ranges of the respective parameter of
interest (BMI, activity, and disordered eating), several limitations
should be acknowledged as well. In the present study we only
assessed fasting bile acid levels. However, since food intake and
especially food components affect the bile acid release also the
postprandial bile acid response should be monitored. Ideally,
also the diet should be controlled which was not possible
in the present study. In addition, the groups studied were
inhomogeneous with regards to comorbidities: e.g., diabetes
mellitus type 2, hypercholesterinemia and statin treatment.
Although no association between glucose or cholesterol levels
and circulating bile acids was detected, subgroup analyses were
not possible in the present study due to the sample size. Future
studies should be performed with larger populations in order
to allow for the analysis of adequately sized samples or after
exclusion of patients with possibly confounding comorbidities.
Moreover, the present study assessed total bile acid levels and
therefore cannot comment on special subtypes of bile acids.
Lastly, in order to further assess a cause-consequence relationship
a longitudinal study should be performed assessing bile acids e.g.,
after weight loss in obese patients.
In summary, we show that plasma bile acids display a positive
association with body mass index and may be involved in
the regulation of body weight. No correlations were observed
for circulating bile acids and parameters of physical activity
and energy expenditure, at least not under conditions of
greatly reduced body weight in patients with anorexia nervosa.
Interestingly, total plasma bile acids show a negative association
with the cognitive restraint of eating in obese patients with
various levels of disordered eating, which may give rise
to a compensatory biological mechanism to prevent further
overeating and subsequently body weight gain in obese subjects.
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